| |
| | World Intellectual Property Organization |
 | | Uridine 5'-triphosphate (UTP) and ATP have been shown to activate the P2Y subtypes of purinergic receptors in multiple glial cells of the central, peripheral, and sensory nervous systems, including oligociendrocytes, astrocytes, Müller cells, retinal pigment epithelium, and resident |
 | | The method comprises administering to the ocular surfaces of the subject a purinergic receptor agonist such as uridine 5'-triphosphate, cytidine 5'-triphosphate, adenosine 5'-triphosphate, or their analogs and derivatives, in an amount effective to stimulate tear fluid secretion. |
 | | USPN 5,763,447 is directed to a method of preventing or treating pneumonia, including ventilator-associated pneumonia, in a bedridden or immobilized subject in need of such treatment. |
| www.wipo.int /ipdl/IPDL-CIMAGES/view/pct/getbykey5?KEY=01/87913.011122&ELEMENT_SET=DECL |
|